Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,806 | 31,087 | 52,891 | 44,200 | 81,461 |
| Marketable Securities | 67,350 | 117,950 | 139,212 | 164,660 | 155,871 |
| Receivables | 37,995 | 31,082 | 26,962 | 37,923 | 32,280 |
| Inventories | 3,476 | 2,769 | 3,043 | 3,105 | 3,672 |
| TOTAL | $208,540 | $198,366 | $233,921 | $263,222 | $291,381 |
| Non-Current Assets | |||||
| PPE Net | 628 | 719 | 606 | 686 | 766 |
| Other Non-Current Assets | 4,809 | 5,373 | 5,911 | 6,052 | 5,683 |
| TOTAL | $5,437 | $6,092 | $6,517 | $6,738 | $6,449 |
| Total Assets | $213,977 | $204,458 | $240,438 | $269,960 | $297,830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,797 | 5,028 | 3,123 | 943 | 2,287 |
| Accrued Expenses | 49,809 | 54,851 | 61,394 | 55,713 | 51,808 |
| Other current liabilities | 1,468 | 2,037 | 1,654 | 2,228 | 1,749 |
| TOTAL | $57,619 | $65,341 | $69,479 | $62,079 | $58,928 |
| Non-Current Liabilities | |||||
| Long Term Debt | 93,517 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 194,981 | 308,072 | 307,165 | 308,277 | 310,150 |
| TOTAL | $288,498 | $308,072 | $307,165 | $308,277 | $310,150 |
| Total Liabilities | $346,117 | $373,413 | $376,644 | $370,356 | $369,078 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,316 | 7,851 | 7,675 | 7,639 | 7,627 |
| Common Shares | 13 | 12 | 12 | 12 | 12 |
| Retained earnings | -1,500,608 | -1,524,400 | -1,487,038 | -1,445,201 | -1,410,695 |
| Other shareholders' equity | -605 | -518 | -161 | -742 | -783 |
| TOTAL | $-132,140 | $-168,955 | $-136,206 | $-100,396 | $-71,248 |
| Total Liabilities And Equity | $213,977 | $204,458 | $240,438 | $269,960 | $297,830 |